Sunesis Pharmaceuticals, Inc. (SNSS) Appoints Joseph I. Depinto As Chief Commercial Officer, Updates VALOR Timeline To Unblinding Of Data
2/10/2014 9:10:24 AM
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced the appointment of Joseph I. DePinto to the newly created position of Executive Vice President and Chief Commercial Officer. Mr. DePinto brings over two decades of experience in global commercial operations, including the leadership of the commercial, marketing and strategic development efforts behind a number of prominent oncology products.
Help employers find you! Check out all the jobs and post your resume.
comments powered by